Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00875758 · ClinicalTrials.gov registry record · NA
Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00875758: Completed NA study, sponsored by Washington University School of Medicine.
NCT00875758 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00875758, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Intraventricular hemorrhage remains the most frequent, severe neurological complication of prematurity, occurring in 25-30% of preterm infants. Post-hemorrhagic ventricular dilation (PHVD) occurs in 25-50% of those infants, with over half requiring ventriculoperitoneal shunts. When suboptimally untreated, PVHD results in a 3-4 fold increase in neurodevelopmental delay. Despite the lifelong impact of PHVD on quality of life, little research has been done over the past 20 years to improve patient outcomes. The CENTRAL HYPOTHESIS of this project is that early treatment of PHVD will reduce shunt-dependence and improve neurodevelopmental outcome in preterm infants.
Interventions
- PROCEDURE Removal of CSF through ventricular access device
- PROCEDURE Removal of CSF through a ventricular access device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT00875758 record still lists
NCT00875758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Removal of CSF through ventricular access device is the first listed.
NCT00875758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00875758 about?
NCT00875758 is a clinical study titled "Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants". Intraventricular hemorrhage remains the most frequent, severe neurological complication of prematurity, occurring in 25-30% of preterm infants. Post-hemorrhagic ventricular dilation (PHVD) occurs in 25-50% of those infants, with over half requiring ventriculoperitoneal shunts. When suboptimally untr...
What is the current status of trial NCT00875758?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2009-05. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00875758?
The interventions under investigation include: Removal of CSF through ventricular access device (PROCEDURE), Removal of CSF through a ventricular access device (PROCEDURE).
Who is sponsoring clinical trial NCT00875758?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00875758's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia